Latest News
Long-acting injectable treatment better than daily tablets for young people living with HIV
Having injections every 8 weeks was better at keeping HIV under control than daily tablets among young people living with HIV, according to results from the LATA trial.
Children with severe pneumonia could leave hospital sooner with oral antibiotics
The PediCAP trial shows that it is safe to switch children in hospital with severe pneumonia from injectable to oral antibiotics once their health improves.
Our HIV research at the AIDS 2026 Conference in Brazil
Researchers from our teams and partner institutions will showcase their latest work on HIV trials at the 26th International AIDS Conference (26-31 July).
Global NeoSep1 trial expands to India to tackle neonatal sepsis
The first infant has been enrolled in India as NeoSep1 extends recruitment across the Asia-Pacific region to evaluate antibiotic treatments for neonatal sepsis.